Author: Ian M. Anderson
Publisher: CRC Press
Release Date: 2004-09-20
This book brings together leading UK psychiatrists and psychopharmacologists to review and clarify essential information about the scientific background and clinical applications of the drugs used in psychiatry. Based on the excellent Psychopharmacology Course for Psychiatrists in Training, organized twice a year by the British Association for Psychopharmacology, Fundamentals of Clinical Psychopharmacology reflects the individual lectures that make up the course, ranging from basic neuroscience to the analysis of clinical trials. The book is updated regularly, and this Second Edition includes a helpful new chapter on child and adolescent psychopharmacology.
Author: Brian E. Leonard
Publisher: John Wiley & Sons
Release Date: 2004-05-03
Treatment with drugs is fundamental to modern therapy of psychiatric disorders. The number of disorders responsive to drug treatment is increasing, reflecting the extensive synthesis of novel compounds and the greater understanding of the aetiology of the disorders. This third edition provides new and updated material, including an additional chapter on clinical trials and their importance in assessing the efficacy and safety of psychotropic drugs. As molecular biology and imaging techniques are of increasing importance to basic and clinical neuroscience, these areas have also been extended to illustrate their relevance to our understanding of psychopharmacology. This book is essential reading for undergraduates in pharmacology and the neurosciences, postgraduate neuropharmacologists, psychiatrists in training and in practice and medical researchers. Reviews of the Second Edition "...this text is eminently readable, well researched, and probably the best of its kind. The book is well worth buying and anyone who claims to know anything about psychopharmacology will be expected to have a heavily annotated copy." Irish Journal of Psychological Medicine "...[this is] a very good book, especially suited to those interested in psychopharmacologic research and psychiatric residency in training." Journal of Chemical Neuroanatomy
Author: Alan F. Schatzberg
Publisher: American Psychiatric Pub
Release Date: 2013
This third edition of Essentials of Psychopharmacology is, like its predecessors, based on the premier textbook in the field, The American Psychiatric Publishing Textbook of Psychopharmacology, now in its fourth edition. The Essentials format is designed to deliver core knowledge to the busy trainee or practitioner in a succinct and accessible manner. Essentials of Psychopharmacology provides a complete overview of clinically focused pharmacotherapeutic principles of vital interest to psychiatry residents, primary care physicians, and other health care professionals. Updated with the latest research findings since the publishing of the fourth edition, Essentials features new chapters on recently introduced medications and updated chapters on others. The book is divided into two parts: Classes of Psychiatric Treatments, which systematically reviews psychotropic medications within each drug class (e.g., antidepressants and anxiolytics, antipsychotics), and Psychopharmacological Treatment, which outlines current pharmacotherapeutic approaches in the major psychiatric disorders as well as in specific patient populations. Although the latter part has been streamlined in this new edition, coverage of critical information such as approved indications, drug interactions, side effects, and other prescribing factors remains comprehensive. Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.
Author: Alan F. Schatzberg
Publisher: American Psychiatric Pub
Release Date: 2015-04-28
Standard of care in psychiatry requires that practitioners stay current on new agents, interactions, side effects, and dosing guidelines -- a daunting task for the modern clinician grappling with today's challenging medical environment. The Manual of Clinical Psychopharmacology has been the psychiatrist's trusted companion for nearly three decades, and this new, eighth edition delivers the cutting-edge information clinicians need in a down-to-earth style, facilitating the integration of biological and psychopharmacological information into practice. The book's primary purpose is to provide the reader-practitioner with a practical, usable clinical guide to the selection and prescription of appropriate drug therapies for individual patients, drawing on the authors' clinical experience as well as on the scientific literature. Students of psychiatry and psychopharmacology also will find the book useful as both text and reference. The eighth edition retains many of its most popular features, while adding others to enhance coverage and promote comprehension: Some sections dealing with less commonly used drugs (e.g., barbiturates) have been shortened or eliminated, making space for the huge number of new agents that have been approved (e.g., vortioxetine) or are likely to receive approval from the U.S. Food and Drug Administration (FDA). This makes the volume easier to use. The book has been thoroughly updated to reflect the release of DSM-5, which introduced dimensional measures of key dimensions (e.g., anxiety and depression) across diagnostic categories to better describe patients' disorders. In the chapter on diagnosis and classification, the authors review these major changes and the implications for prescribing. Features of particular utility for students include the introductory chapter on the general principles of psychopharmacological treatment and the summary medication tables, which serve as quick-reference guides on classes of psychotropics. Although largely evidence-based, the authors also draw on their extensive clinical experience in discussing various drugs' efficacy, dosing and side effects and other important factors. Two appendixes offer suggested readings for clinicians and for patients and families, as well as information on strengths and costs of antidepressant and antipsychotic drugs. There has never been a more meticulously researched and referenced guide to prescribing psychotropic medications, nor one more down-to-earth and practical. The Manual of Clinical Psychopharmacology richly deserves its reputation as a classic in the field and has earned a place on every psychiatrist's desk.
Author: Alan F. Schatzberg
Publisher: American Psychiatric Pub
Release Date: 2009
Now updated to keep professionals current with the latest research and trends in the field, this edition covers both basic science and clinical practice, and draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy.
Author: Paul F. Smith
Release Date: 2013-02-01
This volume provides a concise introduction to the physiological, biochemical, and behavioral issues surrounding drug interventions in the treatment of psychological and neurological disorders. It was written for the reader who does not have an extensive background in these subjects but would like an accurate, current, and succinct account of clinical psychopharmacology. Descriptions of the drugs used to treat psychological disorders such as anxiety, depression, and psychosis; and neurological disorders such as chronic pain, epilepsy, and Parkinson's disease constitute the major portions of this book. There is also coverage of drugs of abuse as well as issues specific to the problems of prescribing and monitoring drug treatment in pediatric and geriatric populations. To help avoid the possibility of brand name confusion, pharmacological names for drugs are used. A convenient table matches the generic names with lists of brand names available in the United States. As such, this volume will be a valuable guide for psychology and clinical psychology students as well as nurses and medical students.
Author: Ian Stolerman
Publisher: Springer Science & Business Media
Release Date: 2010-07-31
Here is a broad overview of the central topics and issues in psychopharmacology, biological psychiatry and behavioral neurosciences, with information about developments in the field, including novel drugs and technologies. The more than 2000 entries are written by leading experts in pharmacology and psychiatry and comprise in-depth essays, illustrated with full-color figures, and are presented in a lucid style.
Author: Ian M. Anderson
Publisher: CRC Press
Release Date: 2015-08-18
Fundamentals of Clinical Psychopharmacology provides up-to-date, evidence-based and unbiased information about psychopharmacology. It spans the range of the discipline, from mode of action and side effects of drugs to meta-analyses of clinical trials. It is anchored to practice guidelines produced by the UK National Institute for Health and Care Excellence (NICE) and the British Association for Psychopharmacology (BAP). Care has been taken to provide an international perspective that makes it equally useful to practitioners in the US and other countries. The book grew out of BAP courses that set the standard for professional psychopharmacological education in the UK. This latest edition is fully updated and provides, in a concise and easy-to-read format, key facts about currently used psychotropic drugs, set in the context of the neuroscience of the disorders they treat. It also includes a new chapter on the principles of psychiatric prescribing. Key references, including the clinical studies discussed, are provided at the end of the chapter along with suggestions for further reading. Intended to be a frequently updated, affordable, concise and practical resource, it meets the needs of trainees and practitioners seeking to keep abreast of the state of the art in psychopharmacology.
Author: Arash Ansari; David N. Osser
Publisher: Author House
Release Date: 2009-08-13
PSYCHOPHARMACOLOGY FOR MEDICAL STUDENTS is a concise overview of basic pharmacological therapies commonly used in psychiatry. The biological and clinical aspects of the use of antidepressants, anxiolytics, antipsychotics, mood stabilizers, and ADHD and substance abuse medications are briefly discussed. Following each section, a table with the clinical characteristics and indications of individual medications in each group is provided. Although this book was written with 3rd and 4th year medical students in mind (covering both what is needed during clinical rotations as well as for end of rotation exams), it is also likely to be a helpful introduction for beginning residents and physicians. Other mental health professionals who need to have a functional knowledge of psychopharmacology may benefit from this overview as well. Finally, laypersons with an academic or personal interest in this topic may also find this book useful.
Author: John D. Preston
Publisher: New Harbinger Publications
Release Date: 2017-03-01
The Handbook of Clinical Psychopharmacology for Therapists is the go-to resource for mental health clinicians looking for clear, reliable information about the treatment of mental health issues. Organized by disorder and, within each disorder, by medication, this book is designed to familiarize clinicians and students with the basic terminology and models of pharmacokinetics. This fully revised and updated eighth edition provides essential information on new medications and treatment options and includes the latest research on side effects, contraindications, and efficacy of all major medications prescribed for mental health disorders. The book also features an important new chapter on the effects of withdrawing from psychopharmacological medications. This handbook makes it simple to: get the facts about drug interactions and side effects; find out how medications affect adults, children, and adolescents differently; learn how different cultures view medical treatment, vital information for anyone who treats clients from a variety of backgrounds; and discontinue medication safely when needed. This essential guide to psychopharmacology has been adopted as a textbook at universities nationwide and is an important resource for every therapist’s library.
Author: Richard C. Stillman
Release Date: 2013-10-22
The Psychopharmacology of Hallucinogens focuses on the properties, compositions, functions, transformations, and reactions of hallucinogens. The selection first offers information on the biosynthesis and action of hallucinogens in mammals; role of biogenic amines in the actions of monomethoxy-amphetamines; and molecular mechanism of action of hallucinogens. The book then takes a look at the molecular determinants for interaction with the LSD receptor, including biological studies, molecular reactivity, and summation of the molecular polarization complexes. The text examines the progress on the development of a receptor model for hallucinogenic amphetamines; characterization of psychotomimetics; physical identification of hallucinogenic compounds; and aspects of the pharmacology of phencyclidine. The book also underscores the effects of LSD, mescaline, and DMT, including effects on humans, proposed model, and effects of monoamine manipulations. The text also presents analysis of hallucinogens by Pavlovian conditioning, behavioral measures of hallucinogenic behavior, and drug model of hallucinosis. The selection is a dependable reference for readers interested in the study of hallucinogens.
Author: Mark Muse
Publisher: John Wiley & Sons
Release Date: 2017-12-26
Genre: Business & Economics
A COMPREHENSIVE, EVIDENCE-BASED APPROACH TO COORDINATING PSYCHOPHARMACOLOGICAL AND PSYCHOTHERAPEUTIC TREATMENTS "Cognitive Behavioral Psychopharmacology: The Clinical Pracrice of Evidence-Based Biopsychosocial Integration represents a significant advance for clinicians seeking to combine evidence-based pharmacological and psychotherapeutic interventions. The contributors represent an impressive array of experts in psychology and psychiatry, and provide an excellent and current synopsis of combined interventions in the various specialty areas of behavioral health". —Morgan T. Sammons, PhD, ABPP, Executive Officer, National Register of Health Service Psychologists "This is an excellent and comprehensive survey of evidence-based treatment in psychiatry. The most refreshing aspect is that the authors explicitly broaden their perspective from psychopharmacology to psychosocial treatments. As a result, after reading a given chapter, one feels confident that all the relevant bases of treatment have been covered." —Daniel Carlat, MD, Editor in Chief, The Carlat Psychiatry Report Cognitive Behavioral Psychopharmacology takes an evidence-based approach to demonstrating the advantages of biopsychosocial integration in interventions for the major psychiatric diagnoses. It is the first and only book to translate the current evidence for cognitive behavioral, psychosocial, and pharmacologic approaches to mental health disorders into clear guidance for clinical practice. There is a burgeoning movement in mental health to acknowledge the entire person's functioning across physical, psychological and social spheres, and to integrate medical as well as psychological and social interventions to address the entire spectrum of presenting problems. This book bridges a gap in the professional mental health literature on the subject of standalone versus combined treatment approaches. It reviews the current state of integrative care, and makes a strong case that optimal outcomes are best achieved by an awareness of how and why the cognitive-behavioral aspects of prescribed medical and psychological interventions influence treatment. Each disorder-specific chapter is authored by a prescriber and psychotherapist team who consider all the evidence around treatments and combinations, providing outcome conclusions and concise tables of recommended front-line interventions. Brings together and compares the current evidence for and against treatments that combine psychopharmacology and cognitive behavioral psychotherapy for major psychiatric diagnoses Outlines an evidence-based approach to determining which combination of treatments is most appropriate for each of the major psychiatric diagnoses Describes, in a way that is accessible to both prescribers and therapists, when and how cognitive behavioral therapy can be integrated into pharmacotherapy The book will appeal to a wide range of mental health professionals, including psychologists, psychiatrists, clinical social workers, licensed professional counselors, marriage and family therapists, and addictions counselors. It also will be of interest to primary care physicians and nurse practitioners who work side by side with mental health professionals.
Author: R. H. Ettinger
Publisher: Psychology Press
Release Date: 2017-02-03
With increases in the prevalence of psychiatric and behavioral disorders and rapid advances in the development of new drug therapies, there is an increasing need to present the science behind these developments. Students and educators are often confronted with conflicting and exaggerated claims about the effectiveness of drugs. As recently as ten years ago, the mechanisms of action of many medications prescribed for common psychological disorders were not well understood, even by the scientists developing them. Now, drug treatment has advanced to a stage where drugs are designed for their effects on specific receptors, membrane proteins, or secondary messengers within particular cells in the brain. This text introduces a sufficient background in neuroanatomy and physiology so students can comprehend the necessary details of drug action. Psychopharmacology, Second Edition, presents its subject matter in the context of the behavioral disorders they are designed to treat, rather than by traditional drug classifications. Students are often familiar with the major diagnostic categories, so presenting psychopharmacology as it pertains to these familiar disorders strengthens their understanding of the physiology and neurochemistry underlying them as well as the approaches to their treatment. Each disorder is discussed from a historical context along with diagnostic criteria and descriptions of typical cases. In addition, what we presently know about the underlying pathology of each disorder is carefully described. A critical examination of drug claims is missing from most psychopharmacology texts, but is offered here. Students will read about the most current research available from a critical perspective. When alternatives to traditional drug therapies are supported by research, these studies are presented as well. Throughout, this text discusses how drug effectiveness is measured in both human and animal studies. Psychopharmacology has contributed significantly over the past 75 years to the treatment of severe psychological disorders as well as to our understanding of the brain and human behavior. This symbiotic relationship between psychopharmacology and the neural and behavioral sciences will continue long into the future. This fully updated second edition is ideal for undergraduate and pre-professional students, and includes a robust companion website.